ATTENTION all of you go-getters and Sherlock Holmes peeps!
I’m calling on my investigative peeps for some support! Here’s a challenge for ya to help the Cushing’s disease (and Cushing’s syndrome) community!
I came across a very curious and interesting post about an alleged clinical trial published in PubMed (I have yet to verify it) that discusses the behavior of glycine-lowering cortisol.
The guy says that for many years, he’s suspected that it’s possible to lower cortisol levels by using inhibiting amino acids that serve as GABA agonists.
These suspicions started because of his experience with pharmaceutical medications that are GABA agonists.
He realized that GABA agonists can actually treat raised cortisol levels in people who have been diagnosed with Cushing’s disease and/or Cushing’s syndrome.
He posted information about a clinical trial using animals as subjects. Given high levels of theanine, their cortisol levels lowered and improved.
Hmmm…sounds plausible, I guess.
And as it turns out, scientists are claiming they can lower cortisol levels in people after actually using a significantly lower dose of theanine. Plus, the effect of the drug stayed at effective levels even after three hours had passed.
Hmmm… Sounds interesting. Sounds VERY interesting. Is this true? Could it be?! And if so, WHY ISN’T THE PHARMACEUTICAL INDUSTRY ALL OVER IT?!
Answer? Hmmm… because some rich Fat Cat who made 25 million dollars last year (don’t get me started about the EpiPen disaster) wants to try and figure out a way to RAISE the cost 400%… just so they can make MORE money.
Do you have Cushing’s? Do you think that a pharmaceutical company would hold off launching a treatment if they knew they could make mega millions more if they simply repackaged the product? Sound off and post on Patient Worthy.